Growth Metrics

KalVista Pharmaceuticals (KALV) Other Non-Current Assets (2016 - 2024)

Historic Other Non-Current Assets for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $1.4 million.

  • KalVista Pharmaceuticals' Other Non-Current Assets changed N/A to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $567000.0 for FY2024, which is N/A changed from last year.
  • KalVista Pharmaceuticals' Other Non-Current Assets amounted to $1.4 million in Q4 2024.
  • KalVista Pharmaceuticals' Other Non-Current Assets' 5-year high stood at $1.4 million during Q4 2024, with a 5-year trough of $106000.0 in Q3 2023.
  • Its 4-year average for Other Non-Current Assets is $411750.0, with a median of $259000.0 in 2021.
  • In the last 5 years, KalVista Pharmaceuticals' Other Non-Current Assets changed by 0.0% in 2020 and then surged by 47075.47% in 2024.
  • Over the past 4 years, KalVista Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $178000.0 in 2020, then increased by 1.69% to $181000.0 in 2021, then soared by 86.19% to $337000.0 in 2023, then soared by 309.2% to $1.4 million in 2024.
  • Its last three reported values are $1.4 million in Q4 2024, $662000.0 for Q4 2024, and $605000.0 during Q3 2024.